SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,113,000 | +44.7% | 24,163 | -5.3% | 0.04% | +42.9% |
| Q2 2016 | $769,000 | 0.0% | 25,519 | +6.3% | 0.03% | +12.0% |
| Q1 2016 | $769,000 | -46.3% | 23,997 | -2.4% | 0.02% | -46.8% |
| Q4 2015 | $1,433,000 | +31.2% | 24,585 | -4.8% | 0.05% | +46.9% |
| Q3 2015 | $1,092,000 | -78.9% | 25,815 | -63.6% | 0.03% | -75.8% |
| Q2 2015 | $5,183,000 | +41.7% | 71,004 | -2.5% | 0.13% | +43.5% |
| Q1 2015 | $3,657,000 | – | 72,797 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |